Genetic variants of human UGT1A3: Functional characterization and frequency distribution in a Chinese Han population

Drug Metabolism and Disposition

Volumn 34, Issue 9, 2006, Pages 1462-1467

  Chen, Yakun ^a   Chen, Shuqing ^a   Li, Xin ^a   Wang, Xiewei ^a   Zeng, Su ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRONE; FLAVONOID; GLUCURONOSYLTRANSFERASE 1A1; GLUCURONOSYLTRANSFERASE 1A3; HYDROXYL GROUP; KAEMPFEROL; LUTEOLIN; QUERCETIN; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ARTICLE; CHINA; CONTROLLED STUDY; ESTROGEN METABOLISM; FUNCTIONAL ASSESSMENT; GENE FREQUENCY; GENETIC VARIABILITY; GLUCURONIDATION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; POPULATION DISTRIBUTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

CHINA; GENE FREQUENCY; GLUCURONIDES; GLUCURONOSYLTRANSFERASE; HUMANS; KAEMPFEROLS; KINETICS; LUTEOLIN; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; QUERCETIN; RECOMBINANT PROTEINS;

EID: 33747847155     PISSN: 00909556     EISSN: 1521009X     Source Type: Journal    
DOI: 10.1124/dmd.106.009761     Document Type: Article

References (40)

1. Bhasker CR, McKinnon W, Stone A, Lo AC, Kubota T, Ishizaki T, and Miners JO (2000) Genetic polymorphism of UDP-glucuronosyltransferase 2B7 (UGT2B7) at amino acid 268: ethnic diversity of alleles and potential clinical significance. Pharmacogenetics 10:679-685.
2. Bosma PJ (1995) The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med 333:1171-1175.
3. Bosma PJ, Seppen J, Goldhoorn B, Bakker C, Oude Elferink RP, Chowdhury JR, and Jansen PL (1994) Bilirubin UDP-glucuronosyltransferase 1 is the only relevant bilirubin glucuronidating isoform in man. J Biol Chem 269:17960-17964.
4. Carlini LE, Meropol NJ, Bever J, Andria ML, Hill T, Gold P, Rogatko A, Wang H, and Blanchard RL (2005) UGT1A7 and UGT1A9 polymorphisms predict response and toxicity in colorectal cancer patients treated with capecitabine/ irinotecan. Clin Cancer Res 11:1226-1236.
5. Chen YK, Chen SQ, Li X, and Zeng S (2005a) Quantitative regioselectivity of glucuronidation of quercetin by recombinant UDP-glucuronosyltransferases 1A9 and 1A3 using enzymatic kinetic parameters. Xenobiotica 35:943-954.
6. Chen YK, Li X, Chen SQ, and Zeng S (2005b) Heterologous expression of active human uridine diphosphate glucuronosyltransferase 1A3 in Chinese hamster lung cells. World J Gastroenterol 11:118-121.
7. Chung JY, Cho JY, Yu KS, Kim JR, Jung HR, Lim KS, Jang IJ, and Shin SG (2005) Effect of the UGT2B15 genotype on the pharmacokinetics, pharmacodynamics, and drug interactions of intravenous lorazepam in healthy volunteers. Clin Pharmacol Ther 77:486-494.
8. Ciotti M, Marrone A, Potter C, and Owens IS (1997) Genetic polymorphism in the human UGT1A6 (planar phenol) UDP-glucuronosyltransferase: pharmacological implications. Pharmacogenetics 7:485-495.
9. da Silva EL, Piskula MK, Yamamoto N, Moon JH, and Terao J (1998) Quercetin metabolites inhibit copper ion-induced lipid peroxidation in rat plasma. FEBS Lett 430:405-408.
10. Ehmer U, Vogel A, Schutte JK, Krone B, Manns MP, and Strassburg CP (2004) Variation of hepatic glucuronidation: novel functional polymorphisms of the UDP-glucuronosyltransferase UGT1A4. Hepatology 39:970-977.
11. Elahi A, Bendaly J, Zheng Z, Muscat JE, Richie JP Jr, Schantz SP, and Lazarus P (2003) Detection of UGT1A10 polymorphisms and their association with orolaryngeal carcinoma risk. Cancer 98:872-880.
12. Galati G, Teng S, Moridani MY, Chan TS, and O'Brien PJ (2000) Cancer chemoprevention and apoptosis mechanisms induced by dietary polyphenolics. Drug Metab Drug Interact 17:311-349.
13. Green MD, King CD, Mojarrabi B, Mackenzie PI, and Tephly TR (1998) Glucuronidation of amines and other xenobiotics catalyzed by expressed human UDP-glucuronosyltransferase 1A3. Drug Metab Dispos 26:507-512.
14. Guillemette C, Ritter JK, Auyeung DJ, Kessler FK, and Housman DE (2000) Structural heterogeneity at the UDP-glucuronosyltransferase 1 locus: functional consequences of three novel missense mutations in the human UGT1A7 gene. Pharmacogenetics 10:629-644.
15. Huang YH, Galijatovic A, Nguyen N, Geske D, Beaton D, Green J, Green M, Peters WH, and Tukey RH (2002) Identification and functional characterization of UDP-glucuronosyltransferases UGT1A8*1, UGT1A8*2 and UGT1A8*3. Pharmacogenetics 12:287-297.
16. Iwai M, Maruo Y, Ito M, Yamamoto K, Sato H, and Takeuchi Y (2004) Six novel UDP-glucuronosyltransferase (UGT1A3) polymorphisms with varying activity. J Hum Genet 49:123-128.
17. Jin C, Miners JO, Lillywhite KJ, and Mackenzie PI (1993) Complementary deoxyribonucleic acid cloning and expression of a human liver uridine diphosphate-glucuronosyltransferase glucuronidating carboxylic acid-containing drugs. J Pharmacol Exp Ther 264:475-479.
18. Jinno H, Saeki M, Tanaka-Kagawa T, Hanioka N, Saito Y, Ozawa S, Ando M, Shirao K, Minami H, Ohtsu A, et al. (2003) Functional characterization of wild-type and variant (T202I and M59I) human UDP-glucuronosyltransferase 1A10. Drug Metab Dispos 31:528-532.
19. Kris-Etherton PM and Keen CL (2002) Evidence that the antioxidant flavonoids in tea and cocoa are beneficial for cardiovascular health. Curr Opin Lipidol 13:41-49.
20. Labrune P, Myara A, Chalas J, Le Bihan B, Capel L, and Francoual J (2002) Association of a homozygous (TA)8 promoter polymorphism and a N400D mutation of UGT1A1 in a child with Crigler-Najjar type II syndrome. Hum Mutat 20:399-401.
21. Levesque E, Beaulieu M, Green MD, Tephly TR, Belanger A, and Hum DW (1997) Isolation and characterization of UGT2B15(Y85): a UDP- glucuronosyltransferase encoded by a polymorphic gene. Pharmacogenetics 7:317-325.
22. Levesque E, Beaulieu M, Hum DW, and Belanger A (1999) Characterization and substrate specificity of UGT2B4 (E458): a UDP-glucuronosyltransferase encoded by a polymorphic gene. Pharmacogenetics 9:207-216.
23. Maruo Y, Iwai M, Mori A, Sato H, and Takeuchi Y (2005) Polymorphism of UDP-glucuronosyltransferase and drug metabolism. Curr Drug Metab 6:91-99.
24. Maruo Y, Nishizawa K, Sato H, Doida Y, and Shimada M (1999) Association of neonatal hyperbilirubinemia with bilirubin UDP-glucuronosyltransferase polymorphism. Pediatrics 103:1224-1227.
25. Miners JO and Mackenzie PI (1991) Drug glucuronidation in humans. Pharmacol Ther 51:347-369.
26. Miners JO, McKinnon RA, and Mackenzie PI (2002) Genetic polymorphisms of UDP-glucuronosyltransferases and their functional significance. Toxicology 181-182:453-456.
27. Moon JH, Tsushida T, Nakahara K, and Terao J (2001) Identification of quercetin 3-O-beta-D-glucuronide as an antioxidative metabolite in rat plasma after oral administration of quercetin. Free Radic Biol Med 30:1274-1285.
28. Morand C, Crespy V, Manach C, Besson C, Demigne C, and Remesy C (1998) Plasma metabolites of quercetin and their antioxidant properties. Am J Physiol 275:R212-R219.
29. Mori A, Maruo Y, Iwai M, Sato H, and Takeuchi Y (2005) UDP-glucuronosyltransferase 1A4 polymorphisms in a Japanese population and kinetics of clozapine glucuronidation. Drug Metab Dispos 33:672-675.
30. O'Leary KA, Day AJ, Needs PW, Sly WS, O'Brien NM, and Williamson G (2001) Flavonoid glucuronides are substrates for human liver beta-glucuronidase. FEBS Lett 503:103-106.
31. Qian MR, Chen SQ, Li X, and Zeng S (2004) Cloning and expression of human UDP-glucuronosyltransferase 1A4 in Bac-to-Bac system. Biochem Biophys Res Commun 319:386-392.
32. Radominska-Pandya A, Czernik PJ, Little JM, Battaglia E, and Mackenzie PI (1999) Structural and functional studies of UDP-glucuronosyltransferases. Drug Metab Rev 31:817-899.
33. Ritter JK, Yeatman MT, Ferreira P, and Owens IS (1992) Identification of a genetic alteration in the code for bilirubin UDP-glucuronosyltransferase in the UGT1 gene complex of a Crigler-Najjar type I patient. J Clin Investig 90:150-155.
34. Scalbert A, Manach C, Morand C, Remesy C, and Jimenez L (2005) Dietary polyphenols and the prevention of diseases. Crit Rev Food Sci Nutr 45:287-3065.
35. Silva MM, Santos MR, Caroco G, Rocha R, Justino G, and Mira L (2002) Structure-antioxidant activity relationships of flavonoids: a re-examination. Free Radic Res 36:1219-1227.
36. Vita JA (2005) Polyphenols and cardiovascular disease: effects on endothelial and platelet function. Am J Clin Nutr 81:292S-297S.
37. Vogel A, Kneip S, Barut A, Ehmer U, Tukey RH, Manns MP, and Strassburg CP (2001) Genetic link of hepatocellular carcinoma with polymorphisms of the UDP-glucuronosyltransferase UGT1A7 gene. Gastroenterology 121:1136-1144.
38. Wells PG, Mackenzie PI, Chowdhury JR, Guillemette C, Gregory PA, Ishii Y, Hansen AJ, Kessler FK, Kim PM, Chowdhury NR, et al. (2004) Glucuronidation and the UDP-glucuronosyltransferases in health and disease. Drug Metab Dispos 32:281-290.
39. Wittig J, Herderich M, Graefe EU, and Veit M (2001) Identification of quercetin glucuronides in human plasma by high-performance liquid chromatography-tandem mass spectrometry. J Chromatogr B Biomed Sci Appl 753:237-243.
40. Zheng SL, Qian MR, Li X, Chen SQ, and Zeng S (2004) Expression of human UGT1A6 in insect cell with baculovirus expression system. Chin J Pharmacol Toxicol 18:444-448.